Baidu
map

国务院发文:推广三明医改!

2016-04-03 司徒阳明 赛柏蓝

近日,国务院批转国家发展改革委关于2016年深化经济体制改革重点工作意见的通知,其中涉及医药部分如下:推广三明医改:协调推动医疗、医保、医药联动改革。巩固完善县级公立医院综合改革,将公立医院综合改革试点城市增加到200个,扩大综合医改试点省份范围,加快建立现代医院管理制度。在部分综合医改试点省推广福建省三明市医改做法和经验。医改试点省增加4个,达到8个,即从江苏、安徽、福建、青海四个试点省增加为陕

近日,国务院批转国家发展改革委关于2016年深化经济体制改革重点工作意见的通知,其中涉及医药部分如下:

推广三明医改:

协调推动医疗、医保、医药联动改革。巩固完善县级公立医院综合改革,将公立医院综合改革试点城市增加到200个,扩大综合医改试点省份范围,加快建立现代医院管理制度。在部分综合医改试点省推广福建省三明市医改做法和经验。

医改试点省增加4个,达到8个,即从江苏、安徽、福建、青海四个试点省增加为陕西、上海、浙江和四川8个省份。公立医院改革的试点城市要增加到200个,试点城市和试点省份增加,对于医药人来说肯定是更忙,现在多少人在去各省、地市的公关的路上。反正忙就是了。

推广三明医改的做法虽然大家都知道,但是主要是政策判断,现在政府算是明确发文了。部分医改试点省份推广三明市的做法,上海应该不会推广,现在带量采购、GPO采购都在试点和推广中,应该不会推广三明。其他三个省份就要看其政策趋势了。三明医改被总结有哪些是核心呢?

在近日召开的由国务院副总理刘延东、国务院医改领导小组组长刘延东主持的专题研讨会上,国务院医改办副主任、国家卫计委副主任马晓伟则在汇报时指出,从第一批综合医改试点省的经验来看,在今后的改革过程中要做到“8个必须”。

1、综合医改必须由党政“一把手”亲自负责,由一个领导分管“三医”工作;

2、基本医保经办必须实现“三保”合一;

3、流通领域改革必须实行“两票制”,进一步压缩药价虚高的“水分”;

4、公立医院改革必须坚持“腾笼换鸟”,建立科学运行新机制;

5、调动医务人员积极性必须要改革人事薪酬制度,实行编制备案制;

6、提升卫生系统整体效率必须加快推进分级诊疗;

7、发挥医保激励约束作用必须加大推进支付方式改革力度;

8、坚持公立医院公益性必须落实政府责任。

70%的地方开展分级诊疗试点

推进公立医院医务人员薪酬制度改革,建立维护公益性、调动积极性、保障可持续的运行新机制。深化基层医疗卫生机构综合改革,加快推进分级诊疗制度建设,在70%左右的地市开展试点。

国务院确定的目标是2017年大病不出县,分级诊疗快速推进势在必行。部分省市开始试点规定一些疾病只能在基层治疗,未来这种确实会不会扩大呢?

医保制度改革

完善基本医疗保险制度,整合城乡居民基本医保制度和经办管理机构,加快医保支付方式改革,推进基本医保全国联网和异地就医结算。实现大病保险全覆盖。研究制定医疗保险和生育保险合并实施试点方案。

医保好消息是新农合和城镇居民医保合一、大病医保、医保全国联网和异地就医结算,都将扩大医保市场,但是以控费为目的的医保支付改革将规范医药市场的野蛮生长。

健全药品供应保障机制,推进药品流通改革,降低药品虚高价格。

药品研发:临床疗效成金标准

全面推进药品医疗器械审评审批制度改革,建立以临床疗效为主导的审评制度,推进仿制药质量和疗效一致性评价,开展药品上市许可持有人制度试点。落实促进社会办医加快发展的若干政策措施。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1286555, encodeId=4d3e1286555be, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515343, encodeId=6b5115153436c, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587316, encodeId=ba3e158e316d3, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75349, encodeId=6f1fe5349d5, content=评价没有积分了吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 03 09:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=)]
    2016-04-04 tidiq
  2. [GetPortalCommentsPageByObjectIdResponse(id=1286555, encodeId=4d3e1286555be, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515343, encodeId=6b5115153436c, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587316, encodeId=ba3e158e316d3, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75349, encodeId=6f1fe5349d5, content=评价没有积分了吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 03 09:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1286555, encodeId=4d3e1286555be, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515343, encodeId=6b5115153436c, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587316, encodeId=ba3e158e316d3, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75349, encodeId=6f1fe5349d5, content=评价没有积分了吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 03 09:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1286555, encodeId=4d3e1286555be, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515343, encodeId=6b5115153436c, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587316, encodeId=ba3e158e316d3, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Apr 04 23:53:00 CST 2016, time=2016-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75349, encodeId=6f1fe5349d5, content=评价没有积分了吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 03 09:33:00 CST 2016, time=2016-04-03, status=1, ipAttribution=)]
    2016-04-03 lyh994

    评价没有积分了吗?

    0

Baidu
map
Baidu
map
Baidu
map